GlassScriptPhysician profile
Eqdam Radhi
NPI 1710155718
$2,532.66
in general payments reported to CMS, 2019-2025
24 companies · $1,149 in 2025
The $1,149 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.13 · 2020: $153 · 2021: $140 · 2022: $195 · 2023: $255 · 2024: $627 · 2025: $1,149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,031.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,031.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $374.45 | 2024-2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $254.93 | 2024-2025 | Caplyta |
| Daiichi Sankyo INC. | $221.94 | 2020-2022 | |
| Axsome Therapeutics, INC. | $214.15 | 2025 | Auvelity |
| Novo Nordisk INC | $176.06 | 2023-2025 | Wegovy |
| Regeneron Healthcare Solutions, INC. | $130.00 | 2023 | Libtayo |
| Teva Pharmaceuticals USA, INC. | $124.92 | 2024 | Uzedy |
| E.R. Squibb & Sons, L.L.C. | $124.55 | 2025 | Cobenfy |
| Aimmune Therapeutics, INC. | $124.55 | 2025 | Zenpep |
| Pharmacosmos Therapeutics INC. | $124.23 | 2021 | |
| Astellas Pharma US INC | $115.38 | 2024 | Xtandi |
| Abbvie INC. | $95.16 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $94.50 | 2025 | |
| Janssen Pharmaceuticals, INC | $89.53 | 2024 | Xarelto |
| Genentech USA, INC. | $48.73 | 2019-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agios Pharmaceuticals, INC. | $40.58 | 2025 | Pyrukynd |
| Boston Scientific Corporation | $38.73 | 2025 | Watchman Flx |
| Exact Sciences Corporation | $31.82 | 2024-2025 | Cologuard Collection Kit |
| Echosens North America, INC. | $29.60 | 2025 | Fibroscan |
| Hologic Sales and Service, LLC | $26.16 | 2025 | Aptima, Thinprep 2000 Processor |
| Glaxosmithkline, LLC. | $22.32 | 2025 | Trelegy Ellipta |
| Pfizer INC. | $14.40 | 2024 | |
| Medline Industries LP | $11.13 | 2020 | |
| Tms Neurohealth Centers INC. | $4.84 | 2025 | Tms Neurohealth Centers INC. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eqdam Radhi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.